KRAS and colorectal carcinoma: We previously described the generation of cetuximab-sensitive CC cells and cetuximab-resistant CC-CR cells from human HCA-7 cells, a WT KRAS/NRAS/BRAF, microsatellite unstable CRC cell line [7].